We are live on ! Find out more
JY

Jeff Yass Susquehanna International Group

AUM $1.28T
1-Year Est. Return 58.89%
 

Jeff Yass is a co-founder of Susquehanna International Group (SIG), a major global trading and market-making firm. SIG is known for options expertise, quantitative trading, and a training culture grounded in probabilistic decision-making. Yass’s firm is influential across derivatives markets even though it is less of a traditional long-only stock-picking franchise.

This Fund
S&P 500
This Quarter Est. Return
+4.86%
1 Year Est. Return
+58.89%
3 Year Est. Return
+161.44%
5 Year Est. Return
+153.95%
10 Year Est. Return
+545.54%
AUM
$667B
AUM Growth
-$78.5B
Cap. Flow
-$15B
Cap. Flow %
-2.25%
Top 10 Hldgs %
32.39%
Holding
14,586
New
1,953
Increased
4,555
Reduced
6,197
Closed
1,571

Top Buys

Rank Stock Value
1
C icon
Citigroup
C
+$1.13B
2
T icon
AT&T
T
+$275M
3
AAPL icon
Apple
AAPL
+$248M
4
DIS icon
Walt Disney
DIS
+$235M
5
NKE icon
Nike
NKE
+$195M

Sector Composition

Rank Sector Weight
1 Miscellaneous 92.82%
2 Technology 1.6%
3 Consumer Discretionary 1.3%
4 Financials 0.99%
5 Communication Services 0.86%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
STON
12151
DELISTED
StoneMor Inc.
STON
$90K ﹤0.01%
39,451
-3,111
-7% -$7.81K
CTT
12152
PUT
DELISTED
CATCHMARK TIMBER TRUST, INC.
CTT
$90K ﹤0.01%
+10,300
New +$91.8K
SY
12153
So-Young International
SY
$233M
$89K ﹤0.01%
+28,046
New +$111K
SYPR icon
12154
Sypris Solutions
SYPR
$39.4M
$89K ﹤0.01%
+35,896
New +$116K
ZEPP
12155
PUT
Zepp Health
ZEPP
$76.4M
$89K ﹤0.01%
4,425
-11,775
-73% -$353K
ENZ
12156
PUT
DELISTED
Enzo Biochem, Inc.
ENZ
$89K ﹤0.01%
27,800
-73,000
-72% -$249K
ORTX
12157
DELISTED
Orchard Therapeutics plc American Depositary Shares
ORTX
$89K ﹤0.01%
6,747
-1,856
-22% -$30.7K
LMDX
12158
DELISTED
LumiraDx Limited Common Shares
LMDX
$89K ﹤0.01%
+10,017
New +$89.2K
ADIL
12159
CALL
Adial Pharmaceuticals
ADIL
$16.7M
$88K ﹤0.01%
52
-32
-38% -$63K
IMCC
12160
PUT
IM Cannabis
IMCC
$2.38M
$88K ﹤0.01%
+15
New +$87.8K
OLB icon
12161
OLB
OLB
$7.35M
$88K ﹤0.01%
+3,311
New +$151K
PNNT
12162
Pennant Park Investment Corp
PNNT
$244M
$88K ﹤0.01%
12,764
-76,098
-86% -$521K
SXC icon
12163
CALL
SunCoke Energy
SXC
$873M
$88K ﹤0.01%
13,400
-66,200
-83% -$439K
TLMD
12164
DELISTED
SOC Telemed, Inc. Class A Common Stock
TLMD
$88K ﹤0.01%
69,298
-21,904
-24% -$43.9K
ETON icon
12165
CALL
Eton Pharmaceutcials
ETON
$1.79B
$87K ﹤0.01%
20,300
-32,500
-62% -$155K
FTEK icon
12166
Fuel Tech
FTEK
$45.6M
$87K ﹤0.01%
62,326
+3,075
+5% +$5.42K
GNE icon
12167
PUT
Genie Energy
GNE
$392M
$87K ﹤0.01%
+15,600
New +$86.2K
IBIO icon
12168
CALL
iBio
IBIO
$69.5M
$87K ﹤0.01%
315
-360
-53% -$137K
AIXC
12169
AIxCrypto Holdings Inc
AIXC
$17.1M
$87K ﹤0.01%
162
-38
-19% -$22.8K
RGS icon
12170
CALL
Regis Corp
RGS
$67.5M
$87K ﹤0.01%
2,505
-515
-17% -$28K
TXMD icon
12171
PUT
TherapeuticsMD
TXMD
$25.7M
$87K ﹤0.01%
4,822
-3,390
-41% -$102K
USOI icon
12172
Credit Suisse AG Credit Suisse X-Links Crude Oil Shares Covered Call ETN
USOI
$40.5M
$87K ﹤0.01%
837
+278
+50% +$29.6K
MTEM
12173
PUT
DELISTED
Molecular Templates, Inc.
MTEM
$87K ﹤0.01%
1,473
+233
+19% +$17.5K
USX
12174
CALL
DELISTED
U.S. Xpress Enterprises, Inc. Class A Common Stock
USX
$87K ﹤0.01%
14,800
-272,300
-95% -$2.04M
FPAC.WS
12175
DELISTED
Far Peak Acquisition Corporation Redeemable Warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50
FPAC.WS
$87K ﹤0.01%
43,640
+22,453
+106% +$55.4K

Similar funds

Jeff Yass's Q4 2021 Portfolio in Review

As of Q4 2021, Jeff Yass held 14,586 positions worth $667B, down 11% from $745B the previous quarter. Its ten largest holdings account for 32% of the portfolio.

Jeff Yass's Q4 2021 filing shows 1,953 new, 4,555 increased, 6,197 reduced and 1,571 closed positions. Its largest new stake was iShares Core MSCI Emerging Markets ETF: 1,306,619 shares worth $78.2M. The largest sale was State Street SPDR S&P 500 ETF Trust, an estimated $2.4B.

By sector, the portfolio is most concentrated in Miscellaneous at 93% of assets, up from 93% a quarter earlier, followed by Technology and Consumer Discretionary.

  • Jeff Yass's largest Q4 2021 buy was iShares Core MSCI Emerging Markets ETF: 1,306,619 shares worth $78.2M.
  • Jeff Yass added most to Citigroup in Q4 2021, an estimated $1.13B increase.
  • Jeff Yass's biggest Q4 2021 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $2.4B.
  • Jeff Yass fully exited Stamps.com, Inc. in Q4 2021, selling an estimated $78.8M.
  • Jeff Yass's ten largest holdings make up 32% of its $667B portfolio in Q4 2021.
  • Jeff Yass opened 1,953 new positions and closed 1,571 in Q4 2021.
  • Jeff Yass's portfolio value fell 11% quarter-over-quarter to $667B.

Based on Susquehanna International Group's 13F filing for Q4 2021, filed 14 Feb 2022.